Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients

Relevance. Human neutrophil antigens (HNAs) are localized on glycoproteins which are positioned on the surface membrane of human neutrophils. Alloantibodies against HNA are implicated in a number of clinical conditions, including immune-mediated neutropenia and transfusion reactions. Genotyping for...

Full description

Bibliographic Details
Main Authors: I. I. Krobinets, N. V. Mineeva, I. O. Bogdanova, A. V. Chechetkin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2020-07-01
Series:Bûlleten' Sibirskoj Mediciny
Subjects:
Online Access:https://bulletin.tomsk.ru/jour/article/view/2859
id doaj-4bd33158ad4e4e6f80e86361f174a44a
record_format Article
spelling doaj-4bd33158ad4e4e6f80e86361f174a44a2021-07-29T08:38:08ZengSiberian State Medical University (Tomsk)Bûlleten' Sibirskoj Mediciny1682-03631819-36842020-07-01192485410.20538/1682-0363-2020-2-48-541620Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patientsI. I. Krobinets0N. V. Mineeva1I. O. Bogdanova2A. V. Chechetkin3Russian Research Institute of Hematology and TransfusiologyRussian Research Institute of Hematology and TransfusiologyRussian Research Institute of Hematology and TransfusiologyRussian Research Institute of Hematology and TransfusiologyRelevance. Human neutrophil antigens (HNAs) are localized on glycoproteins which are positioned on the surface membrane of human neutrophils. Alloantibodies against HNA are implicated in a number of clinical conditions, including immune-mediated neutropenia and transfusion reactions. Genotyping for HNA systems is important in the diagnosis of disorders involving alloimmunization to HNA.Aim. To assess the risk of HNA alloimmunization in donors and patients with hematological diseases in St. Petersburg based on the study of HNA allele and genotype frequencies.Materials and methods. DNA samples of 303 blood donors and 302 hematological patients were obtained and typed for HNA-1, -3, -4, -5. Polymerase chain reactions with homemade sequence-specific primers were used for typing. Genomic DNA was isolated from whole blood by a multistage purification method using the CTAB reagent. The results were detected in real time using the EVAGreen intercalating dye. Pearson’s chi-squared test was used to compare the HNA genotype frequencies in donors, patients with hematological diseases and in other populations.Results. In the study, the frequency of HNA-1bd allele was 0.584–0.588, of HNA-1a – 0.376–0.384, of HNA- 1bc – 0.032–0.036. HNA-1bc allele was represented in the genotypes HNA-1a/bc/bd (0.023–0.036), HNA-1a/bc (0.020–0.043) and HNA-1bc/bd (0.007–0.010). The genotypes HNA-1bc/bc and HNA-1null were not identified. Allele “a” of HNA-3, -4, -5 systems was found in the majority of studied individuals (0.795–0.804; 0.887–0.898; 0.699–0.708). The highest calculated risk of HNA alloimmunization was noted in the absence of HNA-5b, HNA- 1a, HNA-3b, and HNA-4b alleles in the genotype and was 0.250, 0.233, 0.231, and 0.163, respectively.Conclusions. Our data are consistent with the results of studies on the HNA allele and genotype frequencies in populations of Europeans and are significantly different from those of East and Southeast Asia, Africa and South America. The frequencies of HNA-1, -3, -4, -5 alleles and genotypes among donors in St. Petersburg and patients with hematological diseases did not have statistically significant differences. It was shown that the highest calculated risk of alloimmunization was observed in the absence of HNA-5b, HNA-1a, HNA-3b, and HNA-4b alleles in the genotype. These data are consistent with the results of similar studies on populations of white Europeans conducted by other authors.https://bulletin.tomsk.ru/jour/article/view/2859donorneutrophil antigensgenotyping
collection DOAJ
language English
format Article
sources DOAJ
author I. I. Krobinets
N. V. Mineeva
I. O. Bogdanova
A. V. Chechetkin
spellingShingle I. I. Krobinets
N. V. Mineeva
I. O. Bogdanova
A. V. Chechetkin
Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
Bûlleten' Sibirskoj Mediciny
donor
neutrophil antigens
genotyping
author_facet I. I. Krobinets
N. V. Mineeva
I. O. Bogdanova
A. V. Chechetkin
author_sort I. I. Krobinets
title Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
title_short Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
title_full Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
title_fullStr Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
title_full_unstemmed Human neutrophil antigen allele frequencies and assessment of HNA alloimmunisation risk in donors and hematological patients
title_sort human neutrophil antigen allele frequencies and assessment of hna alloimmunisation risk in donors and hematological patients
publisher Siberian State Medical University (Tomsk)
series Bûlleten' Sibirskoj Mediciny
issn 1682-0363
1819-3684
publishDate 2020-07-01
description Relevance. Human neutrophil antigens (HNAs) are localized on glycoproteins which are positioned on the surface membrane of human neutrophils. Alloantibodies against HNA are implicated in a number of clinical conditions, including immune-mediated neutropenia and transfusion reactions. Genotyping for HNA systems is important in the diagnosis of disorders involving alloimmunization to HNA.Aim. To assess the risk of HNA alloimmunization in donors and patients with hematological diseases in St. Petersburg based on the study of HNA allele and genotype frequencies.Materials and methods. DNA samples of 303 blood donors and 302 hematological patients were obtained and typed for HNA-1, -3, -4, -5. Polymerase chain reactions with homemade sequence-specific primers were used for typing. Genomic DNA was isolated from whole blood by a multistage purification method using the CTAB reagent. The results were detected in real time using the EVAGreen intercalating dye. Pearson’s chi-squared test was used to compare the HNA genotype frequencies in donors, patients with hematological diseases and in other populations.Results. In the study, the frequency of HNA-1bd allele was 0.584–0.588, of HNA-1a – 0.376–0.384, of HNA- 1bc – 0.032–0.036. HNA-1bc allele was represented in the genotypes HNA-1a/bc/bd (0.023–0.036), HNA-1a/bc (0.020–0.043) and HNA-1bc/bd (0.007–0.010). The genotypes HNA-1bc/bc and HNA-1null were not identified. Allele “a” of HNA-3, -4, -5 systems was found in the majority of studied individuals (0.795–0.804; 0.887–0.898; 0.699–0.708). The highest calculated risk of HNA alloimmunization was noted in the absence of HNA-5b, HNA- 1a, HNA-3b, and HNA-4b alleles in the genotype and was 0.250, 0.233, 0.231, and 0.163, respectively.Conclusions. Our data are consistent with the results of studies on the HNA allele and genotype frequencies in populations of Europeans and are significantly different from those of East and Southeast Asia, Africa and South America. The frequencies of HNA-1, -3, -4, -5 alleles and genotypes among donors in St. Petersburg and patients with hematological diseases did not have statistically significant differences. It was shown that the highest calculated risk of alloimmunization was observed in the absence of HNA-5b, HNA-1a, HNA-3b, and HNA-4b alleles in the genotype. These data are consistent with the results of similar studies on populations of white Europeans conducted by other authors.
topic donor
neutrophil antigens
genotyping
url https://bulletin.tomsk.ru/jour/article/view/2859
work_keys_str_mv AT iikrobinets humanneutrophilantigenallelefrequenciesandassessmentofhnaalloimmunisationriskindonorsandhematologicalpatients
AT nvmineeva humanneutrophilantigenallelefrequenciesandassessmentofhnaalloimmunisationriskindonorsandhematologicalpatients
AT iobogdanova humanneutrophilantigenallelefrequenciesandassessmentofhnaalloimmunisationriskindonorsandhematologicalpatients
AT avchechetkin humanneutrophilantigenallelefrequenciesandassessmentofhnaalloimmunisationriskindonorsandhematologicalpatients
_version_ 1721253239734665216